Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Large Granular Lymphocytic | 6 | 2018 | 24 | 0.750 |
Why?
|
Leukemia, Myeloid, Acute | 8 | 2024 | 3602 | 0.660 |
Why?
|
Quinazolinones | 1 | 2016 | 223 | 0.480 |
Why?
|
Purines | 1 | 2016 | 605 | 0.420 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1596 | 0.390 |
Why?
|
STAT3 Transcription Factor | 4 | 2018 | 877 | 0.370 |
Why?
|
STAT5 Transcription Factor | 3 | 2016 | 264 | 0.340 |
Why?
|
Antineoplastic Agents | 7 | 2024 | 13630 | 0.330 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1547 | 0.280 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2018 | 5253 | 0.250 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2019 | 380 | 0.230 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2024 | 83 | 0.230 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2024 | 310 | 0.220 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 2023 | 48 | 0.220 |
Why?
|
Drug Screening Assays, Antitumor | 4 | 2018 | 717 | 0.210 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1765 | 0.200 |
Why?
|
Mutation | 15 | 2020 | 29932 | 0.190 |
Why?
|
Genes, T-Cell Receptor | 1 | 2020 | 30 | 0.190 |
Why?
|
Janus Kinases | 2 | 2018 | 250 | 0.170 |
Why?
|
Chromosome Deletion | 1 | 2024 | 1387 | 0.160 |
Why?
|
Tandem Repeat Sequences | 1 | 2018 | 180 | 0.150 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2018 | 495 | 0.150 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2017 | 23 | 0.150 |
Why?
|
Mutation, Missense | 3 | 2015 | 2566 | 0.140 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6131 | 0.140 |
Why?
|
High-Throughput Screening Assays | 3 | 2017 | 944 | 0.140 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2020 | 557 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2023 | 1407 | 0.140 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 935 | 0.130 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2016 | 76 | 0.130 |
Why?
|
src Homology Domains | 2 | 2015 | 361 | 0.130 |
Why?
|
Rad51 Recombinase | 1 | 2016 | 188 | 0.120 |
Why?
|
Genes, Homeobox | 1 | 2016 | 284 | 0.120 |
Why?
|
Drug Resistance, Multiple | 1 | 2016 | 254 | 0.120 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 685 | 0.120 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2016 | 124 | 0.120 |
Why?
|
Receptor, EphA7 | 1 | 2014 | 7 | 0.120 |
Why?
|
Cytarabine | 1 | 2016 | 696 | 0.120 |
Why?
|
Drug Synergism | 1 | 2018 | 1754 | 0.120 |
Why?
|
Mycobacterium Infections | 1 | 2014 | 121 | 0.110 |
Why?
|
Arthritis, Rheumatoid | 2 | 2020 | 3763 | 0.110 |
Why?
|
Sezary Syndrome | 1 | 2014 | 78 | 0.110 |
Why?
|
Agammaglobulinemia | 1 | 2014 | 173 | 0.110 |
Why?
|
Clone Cells | 1 | 2016 | 1660 | 0.110 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 646 | 0.110 |
Why?
|
Tamoxifen | 1 | 2016 | 963 | 0.100 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2001 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2058 | 0.090 |
Why?
|
Cell Line, Tumor | 5 | 2023 | 16939 | 0.090 |
Why?
|
Small Molecule Libraries | 1 | 2016 | 734 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2020 | 4353 | 0.090 |
Why?
|
Patient Care Team | 1 | 2021 | 2511 | 0.090 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 381 | 0.090 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2011 | 238 | 0.090 |
Why?
|
Genetic Diseases, Inborn | 1 | 2014 | 601 | 0.090 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 854 | 0.080 |
Why?
|
Finland | 2 | 2021 | 603 | 0.080 |
Why?
|
Endometrial Neoplasms | 1 | 2018 | 1357 | 0.080 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4713 | 0.070 |
Why?
|
Aniline Compounds | 3 | 2018 | 1069 | 0.070 |
Why?
|
bcl-X Protein | 2 | 2023 | 413 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1741 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3025 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2016 | 2145 | 0.070 |
Why?
|
Gene Expression Profiling | 6 | 2020 | 9411 | 0.070 |
Why?
|
Cytokines | 1 | 2020 | 7343 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2919 | 0.060 |
Why?
|
Humans | 30 | 2024 | 760621 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2020 | 10181 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3610 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8482 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2016 | 8515 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3218 | 0.050 |
Why?
|
Sulfonamides | 3 | 2018 | 1977 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2014 | 2981 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3446 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2250 | 0.050 |
Why?
|
Disease Progression | 2 | 2016 | 13502 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4312 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4878 | 0.050 |
Why?
|
Complementarity Determining Regions | 1 | 2020 | 149 | 0.040 |
Why?
|
Male | 14 | 2021 | 359744 | 0.040 |
Why?
|
Blast Crisis | 1 | 2020 | 101 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5791 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2016 | 21025 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2020 | 370 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11712 | 0.040 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2020 | 431 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2013 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 877 | 0.040 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2017 | 68 | 0.040 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2017 | 71 | 0.040 |
Why?
|
Adult | 8 | 2020 | 219994 | 0.040 |
Why?
|
Bone Marrow | 2 | 2018 | 2912 | 0.040 |
Why?
|
Gene Deletion | 2 | 2016 | 2668 | 0.040 |
Why?
|
3T3 Cells | 1 | 2018 | 1085 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2020 | 801 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2014 | 3800 | 0.030 |
Why?
|
STAT Transcription Factors | 1 | 2017 | 188 | 0.030 |
Why?
|
Quinacrine | 1 | 2016 | 24 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 469 | 0.030 |
Why?
|
Keratin-5 | 1 | 2016 | 45 | 0.030 |
Why?
|
Keratin-18 | 1 | 2016 | 38 | 0.030 |
Why?
|
Naphthoquinones | 1 | 2016 | 60 | 0.030 |
Why?
|
Middle Aged | 10 | 2021 | 220352 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2020 | 22053 | 0.030 |
Why?
|
Oxazoles | 1 | 2017 | 199 | 0.030 |
Why?
|
Aged | 9 | 2020 | 169152 | 0.030 |
Why?
|
Tetrahydronaphthalenes | 1 | 2016 | 86 | 0.030 |
Why?
|
Remission Induction | 1 | 2021 | 2392 | 0.030 |
Why?
|
WT1 Proteins | 1 | 2016 | 184 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 429 | 0.030 |
Why?
|
Genomics | 1 | 2011 | 5794 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2016 | 328 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2803 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4550 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2018 | 383 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2019 | 715 | 0.030 |
Why?
|
Kallikreins | 1 | 2016 | 231 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2018 | 1342 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 410 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3616 | 0.030 |
Why?
|
Female | 12 | 2021 | 391270 | 0.030 |
Why?
|
Drugs, Investigational | 1 | 2016 | 214 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1557 | 0.030 |
Why?
|
Tretinoin | 1 | 2016 | 519 | 0.030 |
Why?
|
Multigene Family | 1 | 2016 | 1077 | 0.030 |
Why?
|
Apoptosis | 2 | 2023 | 9501 | 0.030 |
Why?
|
Blotting, Western | 1 | 2020 | 5039 | 0.030 |
Why?
|
Mice | 4 | 2023 | 81208 | 0.030 |
Why?
|
Gene Expression | 2 | 2017 | 7588 | 0.030 |
Why?
|
Genomic Instability | 1 | 2016 | 704 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2023 | 11481 | 0.020 |
Why?
|
Dimerization | 1 | 2013 | 891 | 0.020 |
Why?
|
Base Composition | 1 | 2011 | 290 | 0.020 |
Why?
|
Drug Repositioning | 1 | 2013 | 232 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16546 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2017 | 1764 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4264 | 0.020 |
Why?
|
INDEL Mutation | 1 | 2011 | 266 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2016 | 965 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2016 | 929 | 0.020 |
Why?
|
Imidazoles | 1 | 2016 | 1180 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1737 | 0.020 |
Why?
|
Thiazoles | 1 | 2017 | 1511 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2016 | 1077 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6216 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2380 | 0.020 |
Why?
|
Genome, Human | 2 | 2013 | 4417 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2698 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2934 | 0.020 |
Why?
|
Mutagenesis | 1 | 2013 | 1234 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10182 | 0.020 |
Why?
|
Adolescent | 4 | 2020 | 87810 | 0.020 |
Why?
|
Paclitaxel | 1 | 2016 | 1736 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2013 | 7593 | 0.020 |
Why?
|
Th17 Cells | 1 | 2014 | 787 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58995 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9335 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 58741 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1841 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2798 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2176 | 0.020 |
Why?
|
Animals | 4 | 2023 | 167963 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 3105 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2016 | 2529 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12446 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2014 | 2203 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6771 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10446 | 0.010 |
Why?
|
Sequence Analysis, RNA | 1 | 2012 | 2005 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2725 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3775 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4122 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2012 | 2536 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2802 | 0.010 |
Why?
|
Signal Transduction | 2 | 2018 | 23376 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15840 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8313 | 0.010 |
Why?
|
Genetic Variation | 1 | 2016 | 6551 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4742 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5643 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2014 | 3075 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 41335 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14372 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18416 | 0.010 |
Why?
|
Alleles | 1 | 2011 | 6898 | 0.010 |
Why?
|
Genetic Testing | 1 | 2013 | 3531 | 0.010 |
Why?
|
Computational Biology | 1 | 2011 | 3505 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6853 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9585 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21392 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6218 | 0.010 |
Why?
|
DNA | 1 | 2011 | 7233 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 12960 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18137 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14660 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54303 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15789 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 80372 | 0.010 |
Why?
|
Child | 1 | 2018 | 79806 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2013 | 65017 | 0.000 |
Why?
|